GlassScriptPhysician profile
Frank T Bunch
NPI 1780630186
$615.10
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $238 · 2021: $103.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $180.17 | 2019-2020 | |
| Cardiva Medical, INC. | $111.52 | 2019-2021 | |
| Abbott Laboratories | $71.02 | 2019-2021 | |
| Amgen INC. | $58.94 | 2019-2020 | |
| Medtronic Vascular, INC. | $56.39 | 2020 | |
| Janssen Pharmaceuticals, INC | $42.75 | 2021 | |
| Teleflex LLC | $40.34 | 2019 | |
| Z-Medica, LLC | $15.58 | 2019 | |
| Boston Scientific Corporation | $13.63 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.18 | 2021 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Bunch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.